Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


16.04.2018

2 AIDS Res Hum Retroviruses
1 Am J Epidemiol
1 Am J Med
1 BMC Neurol
1 Cancer
3 Clin Infect Dis
7 J Acquir Immune Defic Syndr
2 J Immunol
1 J Med Virol
1 J Pediatr
9 J Virol
1 JAMA
1 Lancet Glob Health
7 Lancet HIV
2 N Engl J Med
2 Nat Med
13 PLoS One
2 PLoS Pathog
3 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS Res Hum Retroviruses

  1. DE FRANCESCO MA, Izzo I, Properzi M, Gargiulo F, et al
    Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience.
    AIDS Res Hum Retroviruses. 2018 Apr 10. doi: 10.1089/AID.2018.0006.
    PubMed     Text format     Abstract available

  2. ELLIOTT J, Fulcher JA, Ibarrondo J, Tanner K, et al
    Comparative Assessment of Small and Large Intestine Biopsies for <i>Ex Vivo</i> HIV-1 Pathogenesis Studies.
    AIDS Res Hum Retroviruses. 2018 Apr 10. doi: 10.1089/AID.2017.0249.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  3. ROSENBERG ES, Bradley H, Buchacz K, McKenney J, et al
    Improving Estimation of HIV Viral Suppression in the United States: A Method to Adjust HIV Surveillance Estimates From the Medical Monitoring Project Using Cohort Data.
    Am J Epidemiol. 2018 Apr 4. pii: 4960883. doi: 10.1093.
    PubMed     Text format     Abstract available


    Am J Med

  4. LOPEZ LUIS BA, Leon-Tavares DM
    Purulent Pneumococcal Pericarditis: an Uncommon Presentation in the Vaccination Era.
    Am J Med. 2018 Apr 10. pii: S0002-9343(18)30301.
    PubMed     Text format    


    BMC Neurol

  5. UENO T, Sato N, Kon T, Haga R, et al
    Progressive multifocal leukoencephalopathy associated with thymoma with immunodeficiency: a case report and literature review.
    BMC Neurol. 2018;18:37.
    PubMed     Text format     Abstract available


    Cancer

  6. TOTA JE, Engels EA, Madeleine MM, Clarke CA, et al
    Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus-infected individuals in the United States.
    Cancer. 2018 Apr 12. doi: 10.1002/cncr.31359.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  7. ROY M, Holmes C, Sikazwe I, Savory T, et al
    Application of a multi-state model to Evaluate Visit Burden and Patient Stability to Improve Sustainability of HIV Treatment in Zambia.
    Clin Infect Dis. 2018 Apr 7. pii: 4964003. doi: 10.1093.
    PubMed     Text format     Abstract available

  8. SEROTA DP, Rosenberg ES, Lockard AM, Rolle CM, et al
    Beyond the Biomedical: PrEP Failures in a Cohort of Young Black Men who have Sex with Men in Atlanta, GA.
    Clin Infect Dis. 2018 Apr 7. pii: 4964699. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. MELLIEZ H, Mary-Krause M, Bocket L, Guiguet M, et al
    Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4).
    Clin Infect Dis. 2018 Apr 4. pii: 4960877. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  10. ARSHAD O, Gadawska I, Sattha B, Cote HCF, et al
    Elevated Cell-Free Mitochondrial DNA in Filtered Plasma Is Associated With HIV Infection and Inflammation.
    J Acquir Immune Defic Syndr. 2018;78:111-118.
    PubMed     Text format     Abstract available

  11. GENBERG BL, Lee H, Hogan JW, Some F, et al
    Point of diagnosis and patient retention in HIV care in western Kenya.
    J Acquir Immune Defic Syndr. 2018 Apr 10. doi: 10.1097/QAI.0000000000001703.
    PubMed     Text format     Abstract available

  12. PERDOMO-CELIS F, Taborda NA, Rugeles MT
    Circulating Cxcr5-Expressing Cd8+T-Cells are Major Producers of Il-21 and Associate with Limited Hiv Replication.
    J Acquir Immune Defic Syndr. 2018 Apr 10. doi: 10.1097/QAI.0000000000001700.
    PubMed     Text format     Abstract available

  13. MUIRU AN, Bibangambah P, Hemphill L, Sentongo R, et al
    Distribution and performance of cardiovascular risk scores in a mixed population of HIV-infected and community-based HIV-uninfected individuals in Uganda.
    J Acquir Immune Defic Syndr. 2018 Apr 11. doi: 10.1097/QAI.0000000000001696.
    PubMed     Text format     Abstract available

  14. BEAULIEU T, Hayashi K, Milloy MJ, Nosova E, et al
    HIV Serostatus and Having Access to a Physician for Regular Hepatitis C Virus Care Among People Who Inject Drugs.
    J Acquir Immune Defic Syndr. 2018;78:93-98.
    PubMed     Text format     Abstract available

  15. BEGLEY R, Das M, Zhong L, Ling J, et al
    Pharmacokinetics of Tenofovir Alafenamide When Co-administered With Other HIV Antiretrovirals.
    J Acquir Immune Defic Syndr. 2018 Apr 10. doi: 10.1097/QAI.0000000000001699.
    PubMed     Text format     Abstract available

  16. PATEL VV, Dange A, Rawat S, Arnsten JH, et al
    Barriers to HIV testing among men who have sex with men in India reached online: implications for interventions.
    J Acquir Immune Defic Syndr. 2018 Apr 10. doi: 10.1097/QAI.0000000000001698.
    PubMed     Text format    


    J Immunol

  17. NISSEN SK, Pedersen JG, Helleberg M, Kjaer K, et al
    Multiple Homozygous Variants in the STING-Encoding TMEM173 Gene in HIV Long-Term Nonprogressors.
    J Immunol. 2018 Apr 9. pii: jimmunol.1701284. doi: 10.4049/jimmunol.1701284.
    PubMed     Text format     Abstract available

  18. PLANCHAIS C, Hocqueloux L, Ibanez C, Gallien S, et al
    Early Antiretroviral Therapy Preserves Functional Follicular Helper T and HIV-Specific B Cells in the Gut Mucosa of HIV-1-Infected Individuals.
    J Immunol. 2018 Apr 9. pii: jimmunol.1701615. doi: 10.4049/jimmunol.1701615.
    PubMed     Text format     Abstract available


    J Med Virol

  19. MOSITES E, Gounder P, Snowball M, Morris J, et al
    Hepatitis A vaccine immune response 22 years after vaccination.
    J Med Virol. 2018 Apr 12. doi: 10.1002/jmv.25089.
    PubMed     Text format     Abstract available


    J Pediatr

  20. EDWARDS LL, Hunt A, Cope-Barnes D, Hensel DJ, et al
    Parent-Child Sexual Communication Among Middle School Youth.
    J Pediatr. 2018 Apr 6. pii: S0022-3476(18)30288.
    PubMed     Text format     Abstract available


    J Virol

  21. ANTHONY C, York T, Bekker V, Matten D, et al
    Correction for Anthony et al., "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope".
    J Virol. 2018;92.
    PubMed     Text format    

  22. BOYER PL, Smith SJ, Zhao XZ, Das K, et al
    Developing and evaluating inhibitors against the RNase H active site of HIV-1 RT.
    J Virol. 2018 Apr 11. pii: JVI.02203-17. doi: 10.1128/JVI.02203.
    PubMed     Text format     Abstract available

  23. NATESAMPILLAI S, Cummins NW, Nie Z, Sampath R, et al
    The proapoptotic, HIV protease generated Casp8p41 when bound and inactivated by Bcl2, is degraded by the proteasome.
    J Virol. 2018 Apr 11. pii: JVI.00037-18. doi: 10.1128/JVI.00037.
    PubMed     Text format     Abstract available

  24. NING J, Zhong Z, Fischer DK, Harris G, et al
    Truncated CPSF6 forms higher order complexes that bind and disrupt HIV-1 capsid.
    J Virol. 2018 Apr 11. pii: JVI.00368-18. doi: 10.1128/JVI.00368.
    PubMed     Text format     Abstract available

  25. DELUCIA DC, Rinaldo CR, Rappocciolo G
    Inefficient HIV-1 trans infection of CD4(+) T cells by macrophages from HIV-1 nonprogressors is associated with altered membrane cholesterol and DC-SIGN.
    J Virol. 2018 Apr 11. pii: JVI.00092-18. doi: 10.1128/JVI.00092.
    PubMed     Text format     Abstract available

  26. LUO X, Yang W, Gao G
    SUN1 regulates HIV-1 nuclear import in a manner dependent on the interaction between the viral capsid and cellular cyclophilin A.
    J Virol. 2018 Apr 11. pii: JVI.00229-18. doi: 10.1128/JVI.00229.
    PubMed     Text format     Abstract available

  27. POLICICCHIO BB, Cardozo EF, Sette P, Xu C, et al
    The dynamics of SIV 2-LTR Circles in the Presence and Absence of CD8(+) Cells.
    J Virol. 2018 Apr 11. pii: JVI.02100-17. doi: 10.1128/JVI.02100.
    PubMed     Text format     Abstract available

  28. REZAEI SD, Lu HK, Chang JJ, Rhodes A, et al
    The pathway to establishing HIV latency is critical to how latency is maintained and reversed.
    J Virol. 2018 Apr 11. pii: JVI.02225-17. doi: 10.1128/JVI.02225.
    PubMed     Text format     Abstract available

  29. BRICAULT CA, Kovacs JM, Badamchi-Zadeh A, McKee K, et al
    Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.
    J Virol. 2018 Apr 11. pii: JVI.00369-18. doi: 10.1128/JVI.00369.
    PubMed     Text format     Abstract available


    JAMA

  30. OSTER AM, France AM, Mermin J
    Molecular Epidemiology and the Transformation of HIV Prevention.
    JAMA. 2018 Apr 9. pii: 2678246. doi: 10.1001/jama.2018.1513.
    PubMed     Text format    


    Lancet Glob Health

  31. MITCHELL S, Gelman A, Ross R, Chen J, et al
    The Millennium Villages Project: a retrospective, observational, endline evaluation.
    Lancet Glob Health. 2018;6:e500-e513.
    PubMed     Text format     Abstract available


    Lancet HIV

  32. MALLEWA J, Szubert AJ, Mugyenyi P, Chidziva E, et al
    Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial.
    Lancet HIV. 2018 Apr 10. pii: S2352-3018(18)30038.
    PubMed     Text format     Abstract available

  33. SEWANKAMBO NK
    HIV incidence and scale-up of prevention in western Kenya.
    Lancet HIV. 2018 Apr 9. pii: S2352-3018(18)30042.
    PubMed     Text format    

  34. BORGDORFF MW, Kwaro D, Obor D, Otieno G, et al
    HIV incidence in western Kenya during scale-up of antiretroviral therapy and voluntary medical male circumcision: a population-based cohort analysis.
    Lancet HIV. 2018 Apr 9. pii: S2352-3018(18)30025.
    PubMed     Text format     Abstract available

  35. HENRICH TJ
    Dolutegravir intensification and HIV persistence: 3 + 1 = 3.
    Lancet HIV. 2018 Apr 6. pii: S2352-3018(18)30064.
    PubMed     Text format    

  36. RASMUSSEN TA, McMahon JH, Chang JJ, Audsley J, et al
    The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial.
    Lancet HIV. 2018 Apr 6. pii: S2352-3018(18)30040.
    PubMed     Text format     Abstract available

  37. THE LANCET HIV
    Commitment needed from South Africa's new president.
    Lancet HIV. 2018;5:e155.
    PubMed     Text format    

  38. PRAYGOD G, Friis H, Filteau S
    Nutritional support to reduce mortality in patients with HIV?
    Lancet HIV. 2018 Apr 10. pii: S2352-3018(18)30047.
    PubMed     Text format    


    N Engl J Med

  39. MEAD PS, Duggal NK, Hook SA, Delorey M, et al
    Zika Virus Shedding in Semen of Symptomatic Infected Men.
    N Engl J Med. 2018;378:1377-1385.
    PubMed     Text format     Abstract available

  40. FELDMANN H
    Virus in Semen and the Risk of Sexual Transmission.
    N Engl J Med. 2018;378:1440-1441.
    PubMed     Text format    


    Nat Med

  41. HOPE TJ
    Inflammation weakens HIV prevention.
    Nat Med. 2018;24:384-385.
    PubMed     Text format    

  42. CHAKRADHAR S
    A tale of two diseases: Aging HIV patients inspire a closer look at Alzheimer's disease.
    Nat Med. 2018;24:376-377.
    PubMed     Text format    


    PLoS One

  43. HUDSON M, Rutherford GW, Weiser S, Fair E, et al
    Linking private, for-profit providers to public sector services for HIV and tuberculosis co-infected patients: A systematic review.
    PLoS One. 2018;13:e0194960.
    PubMed     Text format     Abstract available

  44. KUEHNE A, Koschollek C, Santos-Hovener C, Thorlie A, et al
    Impact of HIV knowledge and stigma on the uptake of HIV testing - Results from a community-based participatory research survey among migrants from sub-Saharan Africa in Germany.
    PLoS One. 2018;13:e0194244.
    PubMed     Text format     Abstract available

  45. MAGNO L, Dourado I, Silva LAVD, Brignol S, et al
    Gender-based discrimination and unprotected receptive anal intercourse among transgender women in Brazil: A mixed methods study.
    PLoS One. 2018;13:e0194306.
    PubMed     Text format     Abstract available

  46. FIGUEROA DB, Tillotson J, Li M, Piwowar-Manning E, et al
    Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067.
    PLoS One. 2018;13:e0195764.
    PubMed     Text format     Abstract available

  47. UNDERWOOD J, De Francesco D, Leech R, Sabin CA, et al
    Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment.
    PLoS One. 2018;13:e0194760.
    PubMed     Text format     Abstract available

  48. PRUKSAPHON K, Intaramat A, Ratanabanangkoon K, Nosanchuk JD, et al
    Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces (Penicillium) marneffei.
    PLoS One. 2018;13:e0195596.
    PubMed     Text format     Abstract available

  49. TOLLEY EE, Guthrie KM, Zissette S, Fava JL, et al
    Optimizing adherence in HIV prevention product trials: Development and psychometric evaluation of simple tools for screening and adherence counseling.
    PLoS One. 2018;13:e0195499.
    PubMed     Text format     Abstract available

  50. KUHN L, Paximadis M, Da Costa Dias B, Loubser S, et al
    Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children.
    PLoS One. 2018;13:e0195514.
    PubMed     Text format     Abstract available

  51. PASQUAU J, Hidalgo-Tenorio C, Montes ML, Romero-Palacios A, et al
    High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial.
    PLoS One. 2018;13:e0195068.
    PubMed     Text format     Abstract available

  52. MAYNE ES, Mayne ALH, Louw SJ
    Pathogenic factors associated with development of disseminated intravascular coagulopathy (DIC) in a tertiary academic hospital in South Africa.
    PLoS One. 2018;13:e0195793.
    PubMed     Text format     Abstract available

  53. ENANE LA, Mokete K, Joel D, Daimari R, et al
    "We did not know what was wrong"-Barriers along the care cascade among hospitalized adolescents with HIV in Gaborone, Botswana.
    PLoS One. 2018;13:e0195372.
    PubMed     Text format     Abstract available

  54. CHOI SKY, Boyle E, Cairney J, Grootendorst P, et al
    Impact of depression and recreational drug use on emergency department encounters and hospital admissions among people living with HIV in Ontario: A secondary analysis using the OHTN cohort study.
    PLoS One. 2018;13:e0195185.
    PubMed     Text format     Abstract available

  55. GUARDO AC, Gomez CE, Diaz-Brito V, Pich J, et al
    Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.
    PLoS One. 2018;13:e0195915.
    PubMed     Text format     Abstract available


    PLoS Pathog

  56. BUGGERT M, Nguyen S, McLane LM, Steblyanko M, et al
    Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease.
    PLoS Pathog. 2018;14:e1006973.
    PubMed     Text format     Abstract available

  57. RICHARDSON SI, Chung AW, Natarajan H, Mabvakure B, et al
    HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.
    PLoS Pathog. 2018;14:e1006987.
    PubMed     Text format     Abstract available


    Vaccine

  58. LAPUENTE D, Ruzsics Z, Thirion C, Tenbusch M, et al
    Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30262.
    PubMed     Text format     Abstract available

  59. IBARZ-PAVON AB, French N
    No changes on viral load and CD4+ T-cell counts following immunization with 7-valent pneumococcal conjugate vaccine among HIV-infected adults in Malawi.
    Vaccine. 2018 Apr 7. pii: S0264-410X(18)30478.
    PubMed     Text format     Abstract available

  60. SPICKNALL IH, Looker KJ, Gottlieb SL, Chesson HW, et al
    Review of mathematical models of HSV-2 vaccination: Implications for vaccine development.
    Vaccine. 2018 Apr 3. pii: S0264-410X(18)30254.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: